Log in to save to my catalogue

Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary sy...

Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary sy...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2566255584

Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis

About this item

Full title

Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis

Publisher

Oxford: Oxford University Press

Journal title

European heart journal. Cardiovascular pharmacotherapy, 2022-08, Vol.8 (5), p.492-502

Language

English

Formats

Publication information

Publisher

Oxford: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Aim
Optimal dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) intends to balance ischemic and bleeding risks. Various DAPT de-escalation strategies, defined as switching from a full-dose potent to a reduced dose or less potent P2Y12 inhibitor, have been...

Alternative Titles

Full title

Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2566255584

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2566255584

Other Identifiers

ISSN

2055-6837

E-ISSN

2055-6845

DOI

10.1093/ehjcvp/pvab068

How to access this item